Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Jason E. Hill | Researchclopedia

Back to researchers

Jason E. Hill

Astellas Pharma (United States)ORCID

100

Works

5,250

Citations

29

h-index

40

i10-index

Research Topics

Acute Myeloid Leukemia Research Chronic Lymphocytic Leukemia Research Chronic Myeloid Leukemia Treatments

Affiliations

Texas Tech University2013–2016

Research Triangle Park Foundation2005–2005

Cleveland Clinic2004–2009

Target (United States)2005–2006

NewYork–Presbyterian Hospital2014–2014

Top Works

Similar patterns of cortical expansion during human development and evolution

Jason E. Hill,Terrie E. Inder,et al.

2010843 citations

Cancer-related Molecular Pathways

Protein Degradation and Inhibitors

Longitudinal Analysis of Neural Network Development in Preterm Infants

Christopher D. Smyser,Terrie E. Inder,et al.

2010811 citations

A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer

Wenle Xia,Sarah Bacus,et al.

2006377 citations

ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity

Neru Munshi,Sébastien Jeay,et al.

2010319 citations

A Surface-Based Analysis of Hemispheric Asymmetries and Folding of Cerebral Cortex in Term-Born Human Infants

Jason E. Hill,Donna Dierker,et al.

2010307 citations

Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors

Katerina V. Gurova,Jason E. Hill,et al.

2005263 citations

PCR-based subtractive hybridization and differences in gene content among strains of <i>Helicobacter pylori</i>

Natalia S. Akopyants,Arkady F. Fradkov,et al.

1998232 citations

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis,Mehdi Hamadani,et al.

2024167 citations

A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

Mark J. Levis,Alexander E. Perl,et al.

2018144 citations